Kyverna Therapeutics, Inc. (Nasdaq:KYTX)
Health Care/Life Sciences • Biotechnology
CIK 1994702
Company
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Address
5980 Horton Street
Suite 550
Emeryville, California 94608
5980 Horton Street
Suite 550
Emeryville, California 94608
Employees
96
96
Stock Info
Close
$2.6600
$2.6600
Day Range
2.5400 - 2.7800
2.5400 - 2.7800
52 Week Range
2.5010 - 30.6000
2.5010 - 30.6000
Average volume
381.43K
381.43K
Short Interest
3.07M (02/14/25)
3.07M (02/14/25)
% of Float Shorted
15.65%
15.65%
Market Cap
$114.84M
$114.84M
Revenue
N/A
N/A
Net Income
-$60.37M
-$60.37M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
|
Chief Executive Officer & Director Warner Biddle |
|
Independent Director Steve Liapis |
|
Independent Director Mert Aktar |
|
Independent Director Beth C. Seidenberg |
|
Independent Director Daniel K. Spiegelman |
SEC filings
| Date | Form | Event |
|---|---|---|
| 26 Nov, 2024 | 8-K | |
| 26 Nov, 2024 | S-8 | |
| 13 Nov, 2024 | 10-Q | |
| 13 Nov, 2024 | 8-K | |
| 12 Nov, 2024 | SC 13G | |
| 24 Oct, 2024 | 4 | |
| 24 Oct, 2024 | 3 | |
| 21 Oct, 2024 | 8-K | |
| 10 Oct, 2024 | SC 13G | |
| 18 Sep, 2024 | 3 | |
| 18 Sep, 2024 | 3 | |
| 18 Sep, 2024 | 4 | |
| 18 Sep, 2024 | 4 | |
| 16 Sep, 2024 | 8-K | |
| 12 Aug, 2024 | 10-Q | |
| 12 Aug, 2024 | 8-K | |
| 15 Jul, 2024 | 8-K | |
| 11 Jul, 2024 | UPLOAD | |
| 14 Jun, 2024 | 8-K | |
| 10 Jun, 2024 | 4 | |
| 29 May, 2024 | 4 | |
| 14 May, 2024 | 8-K | |
| 14 May, 2024 | 10-Q | |
| 3 May, 2024 | SC 13D | |
| 26 Mar, 2024 | 10-K | |
| 26 Mar, 2024 | 8-K | |
| 22 Feb, 2024 | SC 13G | |
| 20 Feb, 2024 | SC 13G | |
| 14 Feb, 2024 | 4 | |
| 14 Feb, 2024 | 4 | |
| 14 Feb, 2024 | SC 13G | |
| 14 Feb, 2024 | 4 | |
| 14 Feb, 2024 | 4 | |
| 14 Feb, 2024 | 4 | |
| 13 Feb, 2024 | 4 | |
| 13 Feb, 2024 | SEC STAFF | |
| 12 Feb, 2024 | 8-K | |
| 12 Feb, 2024 | 4 | |
| 8 Feb, 2024 | 424B4 | IPO completed |
| 8 Feb, 2024 | S-8 | |
| 8 Feb, 2024 | 3 | |
| 8 Feb, 2024 | CERT | |
| 8 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | EFFECT | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 7 Feb, 2024 | 3 | |
| 6 Feb, 2024 | S-1/A | |
| 5 Feb, 2024 | 8-A12B | |
| 5 Feb, 2024 | CORRESP | |
| 5 Feb, 2024 | CORRESP | |
| 1 Feb, 2024 | S-1/A | |
| 25 Jan, 2024 | CORRESP | |
| 16 Jan, 2024 | CORRESP | |
| 16 Jan, 2024 | S-1 | |
| 10 Jan, 2024 | UPLOAD | |
| 8 Jan, 2024 | DRS/A | |
| 5 Jan, 2024 | DRSLTR | |
| 28 Dec, 2023 | UPLOAD | |
| 15 Dec, 2023 | SEC STAFF | |
| 13 Dec, 2023 | DRSLTR | |
| 13 Dec, 2023 | DRS/A | |
| 21 Nov, 2023 | UPLOAD | |
| 9 Nov, 2023 | DRSLTR | |
| 9 Nov, 2023 | DRS/A | |
| 7 Nov, 2023 | D | |
| 1 Nov, 2023 | UPLOAD | |
| 5 Oct, 2023 | DRS |
Last update:2025-03-06 12:06:50.818483
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.